DNA origami nano-tool provides important clue to cancer

July 7, 2014
Credit: Björn Högberg

Researchers at Karolinska Institutet have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself – but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted. The researchers used the method of DNA origami, in which a DNA molecule is shaped into a nanostructure, and used these structures to test theories about cell signalling.

It was previously known that the EphA2 receptor played a part in several forms of , such as . The ligand, i.e., the protein that communicates with the receptor, is known as an ephrin molecule. Researchers have had a hypothesis that the distance between different ligands – in this case the distance between ephrin molecules – affects the level of activity in the communicating receptor of the adjacent cells.

The Swedish researchers set out to test this hypothesis. They used DNA building blocks to form a stable rod. This has then been used as a very accurate measure of the distance between molecules.

"We use DNA as the construction material for a tool that we can experiment with", says Björn Högberg, principal investigator at the Department of Neuroscience. "The genetic code of the DNA in these structures is less important in this case."

The researchers attached proteins, or ephrins, to the DNA rod at various intervals, for example 40 or 100 nanometres apart. The DNA rods were then placed in a solution containing . In the next step, the researchers looked at how active EphA2 was in these cancer cells.

Placed close together

It turned out that if the ephrin molecules were placed close together on the DNA rod, the receptor in question became more active in the , and the cells also became less invasive in respect of the surrounding cells, which could be an indication that they became less prone to metastasis. This was true even though the amount of protein was the same throughout the experiments, i.e., the number of attached molecules remained the same.

DNA origami nano-tool provides important clue to cancer
Björn Högberg and Ana Teixeira. Credit: Ulf Sirborn

"For the very first time, we have been able to prove this hypothesis: the activity of EphA2 is influenced by how closely spaced the ligands are on the surrounding cells", says Björn Högberg. "This is an important result in itself, but the point of our study is also that we have developed a method for examining how cells react to in a controlled environment, using our custom DNA nano-calipers."

The researchers describe the cell communication as a form of Braille, where the cells somehow sense the patterns of nearby cells, and where the important thing is not only the amount of proteins, but to a great extent the distance between them as well. This study found that a cluster of proteins would communicate more actively than sparsely spaced proteins, even if the concentration was the same.

"This is a model that can help us learn more about the importance of the spatial organization of proteins in the cell membrane to how communicate with each other, something that will hopefully pave the way for a brand new approach to pharmaceuticals in the long term", says Ana Teixeira, a principal investigator at the Department of Cell and Molecular Biology. "Today, the function of the pharmaceuticals is often to completely block proteins or receptors, but it is possible that we should rather look at the proteins in their biological context, where the clustering and placement of various proteins are relevant factors for the effect of a drug. This is probably an area where there is important knowledge to obtain, and this is a way of doing it."

Explore further: Researchers discover disruptions in signaling pathways that enable colorectal cancer cells to form metastases

More information: Spatial Control of Membrane Receptor Function using Ligand Nano–Calipers. Alan Shaw, Vanessa Lundin, Ekaterina Petrova, Ferenc Fördős, Erik Benson, Abdullah Al–Amin, Anna Herland, Andries Blokzijl, Björn Högberg och Ana I. Teixeira. Nature Methods, online July 6 2014; DOI: 10.1038/nmeth.3025

Related Stories

Researchers discover disruptions in signaling pathways that enable colorectal cancer cells to form metastases

March 24, 2014
Researchers at the University of Freiburg have found switches that colorectal cancer cells use to migrate away from the primary tumor site and to invade neighboring tissue. This migration is the first step in metastasis, ...

Team highlights new mechanism explaining how cancer cells spread

May 28, 2014
UT Southwestern Medical Center cancer researchers have identified a protein critical to the spread of deadly cancer cells and determined how it works, paving the way for potential use in diagnosis and eventually possible ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.